07 - 09 September
Unlocking the Secrets of Rare Cells
MiCareo focus on precision medicine and liquid biopsy technology for rare cell isolation, such as circulating tumor cell and tumor-related T cells. We offer a tool for drug developer and researcher to accelerate drug development and biomarker discovery, enabling patient selection and treatment monitoring for cancer therapy. Our fully automated MiSelect R platform starts with whole blood and requires only 5 minutes hands-on time. With a single device and from a single tube of blood, MiCareo’s technology can isolate and profile a single live cell to deliver both biological and genomic information. We are not only capable of characterizing for up to 13 biomarkers analysis with integrated staining and imaging, but also achieving single cell retrieval with high purity for downstream analysis.
So far no information materials were provided for this event. Please contact the organizer directly for further information.
Co-founder and CTO, MiCareo Taiwan Co., Ltd.
Go to profile
21 May. 2019 - 23 May. 2019
The BIOTECHNICA FORUM is the ideal platform for scientific exchange and the discussion of topical issues and areas of ...
What could a fully digitized and networked laboratory of the future look like? smartLAB has been answering this question at ...
21 May. 2019, 10:00 AM - 10:15 AM
Dr. Kathrin Brenker
- Opto Biolabs GbR, Freiburg